
Shares of Medpace Holdings, Inc. (NASDAQ:MEDP) rose sharply in pre-market trading after the company reported strong financial results for the second quarter and raised its full-year guidance.
Medpace expects 2025 revenue to be in the range of $2.42 billion to $2.52 billion, up from prior guidance of $2.14 billion to $2.24 billion. The company also raised its full-year earnings guidance from a range of $12.26 to $13.04 per share, compared to estimates of $13.76 to $14.53 per share.